Aspirin is generally safe for patients with Ménière's disease, with no specific contraindications related to the condition itself, though standard aspirin precautions apply.
Safety Profile in Ménière's Disease
There is no evidence that aspirin is contraindicated or harmful specifically for patients with Ménière's disease. The available guidelines and research do not identify Ménière's disease as a condition requiring aspirin avoidance. The decision to use aspirin should be based on standard safety considerations rather than the presence of Ménière's disease itself.
Important Caveat: Ototoxicity Consideration
While aspirin is not contraindicated in Ménière's disease, there is one theoretical concern worth noting:
- Aspirin can cause reversible tinnitus and hearing loss, particularly at high doses or with chronic use 1
- Ototoxicity typically occurs at serum salicylate concentrations of 19.6 to >67 mg/dL 1
- Since Ménière's disease already causes fluctuating hearing loss and tinnitus, aspirin-induced ototoxicity could theoretically complicate symptom monitoring
- However, this is primarily a concern at therapeutic or toxic doses used for anti-inflammatory purposes, not at the low doses (75-325 mg daily) used for cardiovascular protection
Standard Aspirin Contraindications Apply
Avoid aspirin in patients with Ménière's disease who have 2, 3:
- Allergy to aspirin or NSAIDs (may cause severe allergic reactions including hives, facial swelling, asthma, or shock)
- Active or history of stomach ulcers or GI bleeding
- Bleeding disorders or thrombocytopenia
- Age ≥60 years with increased GI bleeding risk
- Concurrent anticoagulant use (increases bleeding risk 3-6 fold)
- Heavy alcohol use (≥3 drinks daily)
- Aspirin hypersensitivity or aspirin-exacerbated respiratory disease
Clinical Recommendations
For cardiovascular indications: If a patient with Ménière's disease requires aspirin for cardiovascular protection (history of MI, stroke, TIA, or high cardiovascular risk), prescribe it according to standard guidelines 4, 5, 6:
- Dose: 75-325 mg daily (most commonly 81-162 mg)
- Benefits outweigh risks in high-risk cardiovascular patients
Monitor for: Any worsening of tinnitus or hearing loss that could represent aspirin ototoxicity rather than disease progression, particularly if using higher doses.
No specific treatment role: Current evidence does not support aspirin as a treatment for Ménière's disease itself 7, 8, 9. The condition is managed with other interventions (dietary modifications, diuretics, intratympanic steroids, etc.).